Used primarily in the pharmaceutical industry as a key chiral intermediate in the synthesis of triazole antifungal agents, such as voriconazole, which inhibit ergosterol biosynthesis in fungi. It plays a crucial role in the development of these medications, contributing to their efficacy and specificity in treating invasive and systemic fungal infections, particularly in immunocompromised patients. Additionally, it is utilized in research for studying enzyme interactions and designing novel therapeutic compounds with enhanced antifungal properties.